Workflow
LENZ Therapeutics, Inc.(LENZ)
icon
Search documents
LENZ Therapeutics, Inc.(LENZ) - 2021 Q2 - Quarterly Report
2021-08-12 20:13
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to ______ Commission File Number: 001-40532 GRAPHITE BIO, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 84-4867570 ( State or other ...